Andrew Spaventa - Mar 15, 2024 Form 4 Insider Report for Singular Genomics Systems, Inc. (OMIC)

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Stock symbol
OMIC
Transactions as of
Mar 15, 2024
Transactions value $
$0
Form type
4
Date filed
3/19/2024, 05:46 PM
Previous filing
Feb 13, 2024
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +14.6K +149.32% 24.3K Mar 15, 2024 Direct F1
transaction OMIC Common Stock Gift $0 -14.6K -59.89% $0.00 9.77K Mar 15, 2024 Direct F2
transaction OMIC Common Stock Gift $0 +14.6K +0.36% $0.00 4.09M Mar 15, 2024 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F2
holding OMIC Common Stock 2.57K Mar 15, 2024 By Axon Holdings, LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise -14.6K -7.69% 175K Mar 15, 2024 Common Stock 14.6K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Immediately upon vesting of the Reporting Person's RSUs, the Reporting Person transferred his shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F3 Due to an administrative error, 2,569 shares were previously reported as distributed on March 24, 2022, but were not distributed. The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F4 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F5 The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.